Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ploy Pengchata"'
Autor:
Ploy Pengchata, Rungtiwa Pongakasira, Namthip Wongsawangkit, Asa Phichaphop, Nattawut Wongpraparut
Publikováno v:
Journal of Interventional Cardiology, Vol 2023 (2023)
Objectives. This study aimed to determine characteristics and pattern of a calcified nodule (CN) and/or nodular calcification (NC) detected by intravascular ultrasound (IVUS) on the device-oriented composite endpoint (DoCE) in patients with calcified
Externí odkaz:
https://doaj.org/article/3843a8ac37344d62b0e27973c823ae21
Autor:
Nattawut Wongpraparut, Ploy Pengchata, Sudarat Piyophirapong, Pariya Panchavinnin, Rungtiwa Pongakasira, Noppadol Arechep, Kanda Kasetsinsombat, Kittipong Maneechotesuwan
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Indoleamine 2,3 dioxygenase (IDO), the rate-limiting enzyme in the kynurenine (Kyn) pathway of tryptophan (Trp) degradation, is modulated by inflammation, and is regarded as a key molecule driving immunotolerance and immunosuppres
Externí odkaz:
https://doaj.org/article/698cb023d07f4a28b7ae0607bf7cfb26
Publikováno v:
Circulation. 144
Introduction: Impact on clinical outcome of the patient with calcified nodule remain unknown. Calcified nodule may cause suboptimal stent expansion, stent mal-apposition. Hypothesis: We hypothesized that the presence of calcified nodule in the heavy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::babb39f662f45a39eff689569538548b
https://doi.org/10.1161/circ.144.suppl_1.12874
https://doi.org/10.1161/circ.144.suppl_1.12874
Autor:
Kittipong Maneechotesuwan, Ploy Pengchata, Rungtiwa Pongakasira, Sudarat Piyophirapong, Nattawut Wongpraparut
Publikováno v:
European Heart Journal. 41
Background Indoleamine 2,3 dioxygenase (IDO), the rate-limiting enzyme in in the kynurenine (Kyn) pathway of tryptophan (Trp) degradation, is modulated by inflammation and regarded as a key molecule driving immunotolerance and immunosuppressive mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6290f7323e81d1212075260fb63d6380
https://doi.org/10.1093/ehjci/ehaa946.1295
https://doi.org/10.1093/ehjci/ehaa946.1295
Autor:
Kanda Kasetsinsombat, Sudarat Piyophirapong, Noppadol Arechep, Nattawut Wongpraparut, Kittipong Maneechotesuwan, Ploy Pengchata, Pariya Panchavinnin, Rungtiwa Pongakasira
Publikováno v:
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-10 (2021)
Background Indoleamine 2,3 dioxygenase (IDO), the rate-limiting enzyme in the kynurenine (Kyn) pathway of tryptophan (Trp) degradation, is modulated by inflammation, and is regarded as a key molecule driving immunotolerance and immunosuppressive mech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cf4cb5157caf5aaa9ed6af2692db7f8
https://pubmed.ncbi.nlm.nih.gov/34311709
https://pubmed.ncbi.nlm.nih.gov/34311709